Mucormycosis (MCR) has been increasingly described in patients with coronavirus disease
2019 (COVID-19) but the epidemiological factors, presentation, diagnostic certainty, and …

The diagnosis and treatment of mucormycosis are challenging. The incidence of the disease
seems to be increasing. Hematological malignancies are the most common underlying …

Objectives To describe the epidemiology, management and outcome of individuals with
mucormycosis; and to evaluate the risk factors associated with mortality. Methods We …

The novel coronavirus disease (COVID-19) quickly spread to all continents. However, data
regarding all the signs and symptoms of COVID-19 are insufficient. Patients with COVID-19 …

The prevention, diagnosis, and management of infectious disease in transplantation are
major contributors to improved outcomes in organ transplantation. The risk of serious …

Despite the recent introduction of mold-active agents (posaconazole and isavuconazole), in
addition to amphotericin B products, to our armamentarium against mucormycosis, many …

Abstract Coronavirus disease 2019 (COVID-19), may present with a myriad of clinical
manifestations and complications. Patients with COVID-19 are at increased risk of …

Mucormycosis are life-threatening fungal infections especially affecting
immunocompromised or diabetic patients. Despite treatment, mortality remains high (from 32 …

It has been nearly two years since the pandemic caused by the novel coronavirus disease
(COVID-19) has affected the world. Several innovations and discoveries related to COVID …

Abstract Purpose of Review Infectious diseases represent up to 12% of all deaths in people
with diabetes mellitus (DM). The development and progression of DM generate a chronic …